IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc.（IDYA）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · IDYA · 截至 2026年6月8日
活动摘要
买入笔数
1
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
IDEAYA Biosciences, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
IDYA 季度内部人买卖趋势
IDYA 内幕交易卖出 · IDYA 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · IDYA CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
IDYA 高管卖出股份 · IDYA 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 2, 2026 | Stein Jeffrey Director | Purchase | 50,000 | $1.65M⚡ | Form 4 |
| Nov 28, 2025 | Snyder Douglas B. SVP, General Counsel | Award | 1,041 | $18K | Form 4 |
| May 30, 2025 | Snyder Douglas B. SVP, General Counsel | Award | 1,039 | $18K | Form 4 |
| Nov 28, 2025 | Ruiz Briseno Andres See Remarks | Award | 1,253 | $21K | Form 4 |
| Nov 29, 2024 | Ruiz Briseno Andres See Remarks | Award | 682 | $16K | Form 4 |
| Feb 18, 2025 | Hata Yujiro S President and CEO · Director | Option | 12,808 | $250K | Form 4 |
| Jun 27, 2024 | Throne Jason Chief Legal Officer | Option | 47,060 | $330K | Form 4 |
| Jun 27, 2024 | Throne Jason Chief Legal Officer | Option | 6,424 | $86K | Form 4 |
| May 29, 2024 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Option | 28,500 | $367K | Form 4 |
| May 29, 2024 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Sale | 27,649 | $1.00M⚡ | Form 4 |
| May 29, 2024 | WHITE MICHAEL ANTHONY Chief Scientific Officer | Sale | 851 | $31K | Form 4 |
| May 15, 2024 | Hata Yujiro S President and CEO · Director | Option | 83,856 | $361K | Form 4 |
| May 14, 2024 | Hata Yujiro S President and CEO · Director | Option | 56,711 | $244K | Form 4 |
| May 16, 2024 | Hata Yujiro S President and CEO · Director | Option | 34,433 | $148K | Form 4 |
| May 15, 2024 | Hata Yujiro S President and CEO · Director | Sale | 53,592 | $2.28M⚡ | Form 4 |
| May 16, 2024 | Hata Yujiro S President and CEO · Director | Sale | 30,084 | $1.26M⚡ | Form 4 |
| May 14, 2024 | Hata Yujiro S President and CEO · Director | Sale | 54,408 | $2.26M⚡ | Form 4 |
| May 15, 2024 | Hata Yujiro S President and CEO · Director | Sale | 29,761 | $1.29M⚡ | Form 4 |
| May 15, 2024 | Hata Yujiro S President and CEO · Director | Sale | 503 | $22K | Form 4 |
| May 16, 2024 | Hata Yujiro S President and CEO · Director | Sale | 4,349 | $184K | Form 4 |
| May 14, 2024 | Hata Yujiro S President and CEO · Director | Sale | 2,303 | $96K | Form 4 |
| Feb 9, 2024 | Ruiz Briseno Andres See Remarks | Sale | 2,000 | $92K | Form 4 |
| Feb 8, 2024 | Hata Yujiro S President and CEO · Director | Option | 75,815 | $327K | Form 4 |
| Feb 9, 2024 | Hata Yujiro S President and CEO · Director | Option | 23,557 | $102K | Form 4 |
| Feb 9, 2024 | Hata Yujiro S President and CEO · Director | Sale | 23,557 | $1.07M⚡ | Form 4 |
Hata Yujiro S
President and CEO · Director
日期
Feb 18
股数
12,808
均价
$19.52
总金额
$250K
WHITE MICHAEL ANTHONY
Chief Scientific Officer
日期
May 29
股数
28,500
均价
$12.86
总金额
$367K
WHITE MICHAEL ANTHONY
Chief Scientific Officer
日期
May 29
股数
27,649
均价
$36.23
总金额
$1.00M ⚡
Hata Yujiro S
President and CEO · Director
日期
May 15
股数
83,856
均价
$4.31
总金额
$361K
Hata Yujiro S
President and CEO · Director
日期
May 14
股数
56,711
均价
$4.31
总金额
$244K
Hata Yujiro S
President and CEO · Director
日期
May 16
股数
34,433
均价
$4.31
总金额
$148K
Hata Yujiro S
President and CEO · Director
日期
May 15
股数
53,592
均价
$42.57
总金额
$2.28M ⚡
Hata Yujiro S
President and CEO · Director
日期
May 16
股数
30,084
均价
$41.73
总金额
$1.26M ⚡
Hata Yujiro S
President and CEO · Director
日期
May 14
股数
54,408
均价
$41.60
总金额
$2.26M ⚡
Hata Yujiro S
President and CEO · Director
日期
May 15
股数
29,761
均价
$43.48
总金额
$1.29M ⚡
Hata Yujiro S
President and CEO · Director
日期
Feb 9
股数
23,557
均价
$45.54
总金额
$1.07M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 IDYA 内幕交易
IDYA 内幕交易
IDEAYA Biosciences, Inc.（IDYA）内幕交易数据来源于公司内部人（包括Stein Jeffrey (Director), Snyder Douglas B. (SVP, General Counsel), Ruiz Briseno Andres (See Remarks)）提交的SEC Form 4申报文件。过去12个月内，3位内部人向SEC提交了交易申报。IDYA内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看IDEAYA Biosciences, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
IDYA 内幕交易 · 5个问题IDEAYA Biosciences, Inc.（IDYA）的内部人包括高管和董事，如Stein Jeffrey (Director), Snyder Douglas B. (SVP, General Counsel), Ruiz Briseno Andres (See Remarks)等。过去12个月内，3位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026